offering

(BURU) CENTENNIAL, Colo.--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), a global pioneer in high-performance blue laser technology, today announces the closing of its previously announced $12 million public offering. The public offering involved the issuance and sale of $12 million in common stock and pre-funded warrants in lieu of shares, at a subscription price of $0.1428 per share, and $0.1427 per prefunded warrant, representing 32,373,536 common shares and 51,660,075 pre-funded warrants. Ad

(NYSE:DE) Secondary Offering of Ordinary Shares

(BURU) CENTENNIAL, Colo.--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), a global pioneer in high-performance blue laser technology, today announced the pricing of a $12 million public offering, raising significant capital to advance its ambitious transformation strategy. The offering marks a pivotal step in strengthening NUBURU’s position as an emerging leader in the defense and security technology sector. The public offering involved the issuance and sale of $12 million in common stock and pre

(NASDAQ:YYGH) Singapore, Sept. 11, 2025 (GLOBE NEWSWIRE) -- YY Group Holding Limited (Nasdaq: YYGH) (“YY Group” or the “Company”) today announced the amendment of its previously announced registered direct offering.

(NASDAQ:LUCD) NEW YORK, Sept. 11, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the closing of its previously announced underwritten...

(NASDAQ:SLXN) Grand Cayman, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced the pricing of a public offering of an aggregate of  1,500,000 of the Company’s ordinary shares (or ordinary share equivalents), series A warrants to purchase up to  1,500,000 ordinary shares and series B warrants to purchase up to 1,500,000 ordinary shares at a combined public offering price of $4.00 per share (or per ordinary share equivalent) and accompanying warrants. The series A warrants will have an exercise price of $4.00 per share, will be exercisable immediately upon issuance and will expire five years from the date of issuance. The series B warrants will have an exercise price of $4.00 per share, will be exercisable immediately upon issuance and will expire twelve months from the date of issuance. The closing of the offering is ex

(NASDAQ:HSAI) SHANGHAI, China, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Hesai Group (NASDAQ: HSAI) (“Hesai” or the “Company”), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced the pricing of its global offering (the “Global Offering”) of 19,550,000 Class B ordinary shares of the Company (the “Offer Shares”), which comprises an international offering (the “International Offering”) and a Hong Kong public offering (the “Hong Kong Public Offering”).

(NASDAQ:AIRO) ALBUQUERQUE, N.M. & MONTREAL & STØVRING, Denmark & WASHINGTON--(BUSINESS WIRE)-- #AIROGroup--AIRO Group Holdings, Inc. (NASDAQ: AIRO) (“AIRO”), a company specializing in advanced aerospace and defense technologies, today announced the pricing of its upsized underwritten public offering of 4,200,000 shares of its common stock at a public offering price of $18.50 per share. The gross proceeds to AIRO from the offering, before deducting underwriting discounts and commissions and other offering expenses payable

(NASDAQ:WAY) LEHI, Utah and LOUISVILLE, Ky., Sept. 10, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced that certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP...

(NASDAQ:NWS) NEW YORK--(BUSINESS WIRE)--News Corporation (“News Corp” or the “Company”) (NASDAQ: NWSA, NWS; ASX: NWS, NWSLV) today announced the pricing of the previously announced underwritten public offering (the “Offering”) by trusts established for the benefit of Prudence MacLeod, Elisabeth Murdoch and James Murdoch and his or her respective descendants and charitable organizations (the “Selling Stockholders”) of 14,071,293 shares of News Corp’s Class B common stock, par value $0.01 per share (the “Clas

(NASDAQ:AIRO) ALBUQUERQUE, N.M. & MONTREAL & STØVRING, Denmark & WASHINGTON--(BUSINESS WIRE)-- #AIROGroup--AIRO Group Holdings, Inc. (“AIRO”), a company specializing in advanced aerospace and defense technologies, today announced the commencement of an underwritten public offering of 3,500,000 shares of its common stock. AIRO expects to grant the underwriters a 30-day option to purchase up to an additional 525,000 shares (solely to cover over-allotments, if any) of its common stock at the public offering price, less unde

(NASDAQ:SFM) Smithfield Foods Announces Pricing of Upsized Secondary Offering of Common Stock

(NASDAQ:DEFT) TORONTO, Sept. 4, 2025 /PRNewswire/ - DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"), announced today that it has...

(NASDAQ:SSKN) HORSHAM, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the closing of its previously announced registered direct offering for the issuance and sale of 1,097,547 shares of the Company’s common stock at a per share purchase price of $2.204.

$6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants

(NASDAQ:ARTL) SOLANA BEACH, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced the pricing of its previously announced underwritten public offering of 640,924 shares of its common stock at a price to the public of $4.40 per share and pre-funded warrants to purchase up to 40,894 shares of Artelo’s common stock at a price to the public of $4.399 per pre-funded warrant, which represents the per share public offering price of each share of Artelo’s common stock less the $0.001 per share exercise price for each pre-funded warrant. The aggregate gross proceeds from the offering are expected to be approximately $3.0 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purch

(NASDAQ:AGNC) BETHESDA, Md., Sept. 3, 2025 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) ("AGNC" or the "Company") announced today that it has priced a public offering of 12,000,000 depositary shares with a liquidation preference of $25.00 per share (the "Depositary Shares"), for gross proceeds...

(NYSE:CTRI) LAS VEGAS, Sept. 3, 2025 /PRNewswire/ -- Southwest Gas Holdings, Inc. (NYSE: SWX) ("Southwest Gas Holdings" or the "Company") today announced that it will sell 27,362,210 existing shares of Centuri Holdings, Inc. (NYSE: CTRI) ("Centuri") common stock as selling stockholder through a...

(GORO) DENVER--(BUSINESS WIRE)--Gold Resource Corporation (NYSE American: GORO) (the “Company”) today announces that it is pursuing a registered direct offering with certain investors for the purchase and sale of up to 25,315,960 shares of the Company’s common stock at a price of $0.45 per share (the “Shares”), resulting in estimated total gross proceeds of approximately $11.4 million cash (the “Offering”). The Company intends to use approximately $6.4 million of the net proceeds of the Offering to pr

INFORMATION STATEMENT WILL BE ACCESSIBLE THROUGH SEDAR+